Euromedis Groupe SA (ALEMG) - Cash Flow Conversion Efficiency

Latest as of June 2024: 0.036x

Based on the latest financial reports, Euromedis Groupe SA (ALEMG) has a cash flow conversion efficiency ratio of 0.036x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€796.00K ≈ $930.61K USD) by net assets (€22.06 Million ≈ $25.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Euromedis Groupe SA balance sheet quality to measure how much of total assets are equity-financed.

Euromedis Groupe SA - Cash Flow Conversion Efficiency Trend (2009–2022)

This chart illustrates how Euromedis Groupe SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Euromedis Groupe SA to evaluate the quality of earnings relative to operating cash generation.

Euromedis Groupe SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Euromedis Groupe SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
MSCM Holdings Bhd
KLSE:0041
-0.048x
Condor Resources Inc
V:CN
-0.021x
Glennon Small Companies Ltd
AU:GC1
0.011x
Megapolitan Developments Tbk
JK:EMDE
-0.004x
Digital Graphics Incorporation
KQ:043360
0.015x
Priceworth International Bhd
KLSE:7123
-0.039x
Argenica Therapeutics Ltd
AU:AGN
-1.602x
ZOONO Group Ltd
AU:ZNO
-0.356x

Annual Cash Flow Conversion Efficiency for Euromedis Groupe SA (2009–2022)

The table below shows the annual cash flow conversion efficiency of Euromedis Groupe SA from 2009 to 2022. For the full company profile with market capitalisation and key ratios, see ALEMG market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2022-12-31 €34.88 Million
≈ $40.78 Million
€-1.05 Million
≈ $-1.23 Million
-0.030x -106.44%
2021-12-31 €41.24 Million
≈ $48.21 Million
€19.25 Million
≈ $22.50 Million
0.467x +34.56%
2020-12-31 €38.93 Million
≈ $45.51 Million
€13.50 Million
≈ $15.79 Million
0.347x +534.61%
2019-12-31 €17.66 Million
≈ $20.64 Million
€965.00K
≈ $1.13 Million
0.055x +171.22%
2018-12-31 €21.26 Million
≈ $24.86 Million
€-1.63 Million
≈ $-1.91 Million
-0.077x -274.87%
2017-12-31 €27.80 Million
≈ $32.50 Million
€1.22 Million
≈ $1.43 Million
0.044x -12.74%
2016-12-31 €28.81 Million
≈ $33.68 Million
€1.45 Million
≈ $1.69 Million
0.050x -44.13%
2015-12-31 €28.60 Million
≈ $33.44 Million
€2.58 Million
≈ $3.01 Million
0.090x -33.19%
2014-12-31 €25.58 Million
≈ $29.91 Million
€3.45 Million
≈ $4.03 Million
0.135x +31.20%
2013-12-31 €23.42 Million
≈ $27.38 Million
€2.40 Million
≈ $2.81 Million
0.103x -53.88%
2012-12-31 €21.25 Million
≈ $24.85 Million
€4.73 Million
≈ $5.53 Million
0.223x +419.33%
2011-12-31 €20.18 Million
≈ $23.59 Million
€865.00K
≈ $1.01 Million
0.043x -80.00%
2010-12-31 €18.35 Million
≈ $21.46 Million
€3.93 Million
≈ $4.60 Million
0.214x +166.57%
2009-12-31 €17.52 Million
≈ $20.49 Million
€-5.64 Million
≈ $-6.60 Million
-0.322x --

About Euromedis Groupe SA

PA:ALEMG France Medical Distribution
Market Cap
$16.86 Million
€14.42 Million EUR
Market Cap Rank
#26154 Global
#434 in France
Share Price
€5.05
Change (1 day)
+1.00%
52-Week Range
€3.83 - €5.75
All Time High
€24.90
About

Laboratoires Euromedis Société anonyme manufactures, imports, and distributes single-use medical devices for public and private healthcare facilities. It provides gloves; clothing and protection; draping and fields; compresses, cotton, dressings, strips and nets, and skincare products; sets and instrumentation; needles, syringes, microperfusionists; infusion and transfusion services, catheters, a… Read more